109 related articles for article (PubMed ID: 8572620)
1. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer.
Sugimachi K; Maehara Y; Kusumoto T; Okamura T; Korenaga D; Kohnoe S; Baba H; Anai H
Anticancer Res; 1995; 15(5B):2175-9. PubMed ID: 8572620
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.
Nio Y; Tsubono M; Tseng CC; Morimoto H; Kawabata K; Masai Y; Shiraishi T; Imai S; Ohgaki K; Tobe T
Biotherapy; 1992; 4(2):117-28. PubMed ID: 1622733
[TBL] [Abstract][Full Text] [Related]
3. In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Imai S; Tobe T
Cancer Immunol Immunother; 1991; 32(6):335-41. PubMed ID: 1901030
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
[TBL] [Abstract][Full Text] [Related]
6. PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro.
Okuzawa M; Shinohara H; Kobayashi T; Iwamoto M; Toyoda M; Tanigawa N
Int J Oncol; 2002 Jun; 20(6):1189-95. PubMed ID: 12011998
[TBL] [Abstract][Full Text] [Related]
7. Prognostic markers for immunochemotherapy using tegafur -uracil (UFT) and protein-bound polysaccharide K (PSK).
Yoshinaga K; Saeki H; Oki E; Morita M; Ikeda T; Sugimachi K; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Kawanaka H; Mimori K; Watanabe M; Maehara Y
Fukuoka Igaku Zasshi; 2013 Dec; 104(12):549-58. PubMed ID: 24693683
[TBL] [Abstract][Full Text] [Related]
8. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
[TBL] [Abstract][Full Text] [Related]
9. [The restration effect of PSK on the postoperative immunosuppression in patients with gastric cancer].
Notsuka T
Fukuoka Igaku Zasshi; 1985 Sep; 76(9):478-88. PubMed ID: 2417925
[No Abstract] [Full Text] [Related]
10. Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients.
Kanazawa M; Yoshihara K; Abe H; Iwadate M; Watanabe K; Suzuki S; Endoh Y; Takita K; Sekikawa K; Takenoshita S; Ogata T; Ohto H
Anticancer Res; 2005; 25(1B):443-9. PubMed ID: 15816609
[TBL] [Abstract][Full Text] [Related]
11. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
[TBL] [Abstract][Full Text] [Related]
12. Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro.
Noguchi K; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Tani M; Mizobata S; Hotta T; Arii K; Tamai M
Anticancer Res; 1995; 15(2):255-8. PubMed ID: 7762991
[TBL] [Abstract][Full Text] [Related]
13. [Immunoregulatory effects of PSK on the Th1/Th2 balance and regulatory T-cells in patients with colorectal cancer].
Yoshino S; Yoshimura K; Suzuki N; Iida M; Yoshida S; Maeda Y; Maeda K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2234-6. PubMed ID: 21224532
[TBL] [Abstract][Full Text] [Related]
14. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide.
Kato M; Hirose K; Hakozaki M; Ohno M; Saito Y; Izutani R; Noguchi J; Hori Y; Okumoto S; Kuroda D
Cancer Immunol Immunother; 1995 Mar; 40(3):152-6. PubMed ID: 7728773
[TBL] [Abstract][Full Text] [Related]
15. [Compound therapy including PSK for malignant head and neck cancer].
Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters.
Ohwada S; Ogawa T; Makita F; Tanahashi Y; Ohya T; Tomizawa N; Satoh Y; Kobayashi I; Izumi M; Takeyoshi I; Hamada K; Minaguchi S; Togo Y; Toshihiko T; Koyama T; Kamio M
Oncol Rep; 2006 Apr; 15(4):861-8. PubMed ID: 16525672
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of T-cell proliferation by PSK.
Hirai R; Oguchi Y; Sugita N; Matsunaga K; Nomoto K
Int J Immunopharmacol; 1993 Aug; 15(6):745-50. PubMed ID: 8407056
[TBL] [Abstract][Full Text] [Related]
18. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count.
Toge T; Yamaguchi Y
Oncol Rep; 2000; 7(5):1157-61. PubMed ID: 10948356
[TBL] [Abstract][Full Text] [Related]
19. Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells.
Mizutani Y; Nio Y; Yoshida O
J Urol; 1992 Nov; 148(5):1571-6. PubMed ID: 1433570
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
